Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes.
View Sample Report @ http://www.persistencemarketresearch.com/samples/5879
The market of macular degeneration drugs can be segmented on the basis of available and upcoming drugs, such as Lucentis, Eylea, Avastin, Squalamine, Conercept, Lampalizamab and others. Moreover, the market can also be segmented on the basis of stage and type of AMD, such as early AMD, late AMD, dry AMD and wet AMD. Similarly, the market of diabetic retinopathy is also segmented on the basis of available and under pipeline products, such as Lucentis, Optina, Iluvien, Betamethazone, Ozurdex and others. The market can be also segmented on the basis of geography, such as, North America, Europe, Asia-Pacific and Rest of the World (RoW). The North American region is the most lucrative market, owing to large number of elderly population in the U.S. However, European and Asia-Pacific regions are considered as the most promising markets in the upcoming period.
The market for macular degeneration is driven by factors such as change in lifestyle, increased prevalence of various addictions, unhealthy diet, increase in elderly population of the world, and extensive R&D activities. Owing to strong emphasis on R&D, a large number of new drugs are under pipeline studies. The market of diabetic retinopathy is driven by increase in the prevalence of diabetes patients, increase in R&D practices and lack of awareness amongst the population about availability of the sophisticated treatments for diabetes. However, high cost of the R&D and lack of advanced technology in certain regions could act as hurdles for the growth of the market.
Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/5879
Major players operating in the market includes Novartis AG, Bayer Healthcare AG, Roche Ltd., Neurotech Pharmaceuticals, Regeneron Pharmaceuticals, Inc., Allergan, Inc. and others.
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Persistence Market Research Pvt. Ltd
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353